ATAZANAVIR
- Product NDC
- 70710-1052
- 11-digit product format
- 707101052
- Labeler code
- 70710
- Product ID
- 70710-1052_eba93fa3-287b-4174-b304-a9f262e900de
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATAZANAVIR
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA210575
- Marketing category
- ANDA
- Marketing start
- 2021-05-04
- Marketing end
- 0000-00-00
- Substance
- ATAZANAVIR SULFATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70710-1052 | ATAZANAVIR CAPSULE [ZYDUS PHARMACEUTICALS USA INC.] | 3 | Legacy NDC | 20230516_a40c4633-1808-4a28-b4af-769fb36da6c5.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70710-1052-1 | 70710105201 | 100 CAPSULE in 1 BOTTLE (70710-1052-1) | 100 capsule | 2021-05-04 | 0000-00-00 | No | No | Current |
| 70710-1052-3 | 70710105203 | 30 CAPSULE in 1 BOTTLE (70710-1052-3) | 30 capsule | 2021-05-04 | 0000-00-00 | No | No | Current |